Immunovia will share results from the model-development study of its next-generation test to detect stage 1 and 2 pancreatic cancer. In addition, the company provided a grant to fund an educational ...

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.

RefluxStoptm achieves crucial FDA milestone and leaps forward with strong momentum in both the US and Europe Significant events in the third quarter of 2024 First national RefluxStoptm user meetings ...